Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

48

Actual shortage: 7 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 40 (83%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (8%)

Overdue reports

4 (57%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANANDRON 50MG TABLET Actual shortage 2023-09-14 2023-11-18 204346
INHIBACE PLUS 5MG 12.5MG TABLET Resolved 2021-01-04 2021-10-19 130792
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-05-09 2022-05-25 160204
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-08-17 2022-09-30 166884
VALCYTE 450MG TABLET Resolved 2023-05-02 2023-05-25 191490
VALCYTE 450MG TABLET Resolved 2023-09-27 2023-11-05 205325
VALCYTE 450MG TABLET Resolved 2024-01-04 2024-02-01 214848
LOSEC MUPS 20MG TABLET (DELAYED-RELEASE) Actual shortage 2023-12-13 2024-04-26 213267

Showing 41 to 48 of 48

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669

Showing 1 to 4 of 4